HIV-1 reverse transcriptase inhibitor

This page covers all HIV-1 reverse transcriptase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV-1 reverse transcriptase.

Targets

HIV-1 reverse transcriptase

Phase 2 pipeline (1)

• Doravirine, Tenofovir, Lamivudine - Open-Label · Merck Sharp & Dohme LLC · Infectious Diseases
  Doravirine is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), while Tenofovir and Lamivudine are HIV-1 nucleotide reverse transcriptase inhibitors (NtRTIs) and nucleoside reverse transcriptase inhibitors (NRTIs), respectively.